In patients with CKD-induced SHPT, VDRAs mitigate the effects of vitamin D deficiency by binding to vitamin D receptors (VDRs) and inhibiting PTH synthesis through gene transcription regulation.19 The gene discussed is PTH; the disease is vitamin D deficiency.